Platelet-derived major histocompatibility complex class I coating on Treponema pallidum attenuates natural killer cell lethality

References

• Lin LR, Zhu X-Z, Liu D, et al. Are nontreponemal tests suitable for monitoring syphilis treatment efficacy? Evidence from rabbit infection models. Clin Microbiol Infect. 2020;26(2):240–12. doi: 10.1016/j.cmi.2019.06.004
   PubMed Web of Science ®Google Scholar
• Liu D, Liu L-L, Zheng X-Q, et al. Genetic profiling of the full-length tprK gene in patients with primary and secondary syphilis. Microbiol Spectr. 2023;11(3):e0493122. doi: 10.1128/spectrum.04931-22
   PubMed Web of Science ®Google Scholar
• Liu D, Chen R, He Y, et al. Longitudinal variations in the tprK gene of Treponema pallidum in an amoy strain-infected rabbit model. Microbiol Spectr. 2023; 11(4):e0106723. doi: 10.1128/spectrum.01067-23
   PubMed Web of Science ®Google Scholar
• Chen H, Tong ML, Liu LL, et al. The whole process of macrophage-Treponema pallidum interactions: opsonic phagocytosis, nonopsonic phagocytosis and active invasion. 2022; Int Immunopharmacol. 107:108657. doi: 10.1016/j.intimp.2022.108657
   PubMed Web of Science ®Google Scholar
• Zitti B, Bryceson YT. Natural killer cells in inflammation and autoimmunity. Cytokine Growth Factor Rev. 2018;42:37–46. doi: 10.1016/j.cytogfr.2018.08.001
   PubMed Web of Science ®Google Scholar
• Cheng W, Lu Y, Chen R, et al. Decreased blood natural killer cells in serofast patients: a systematic review and meta-analysis. Cent Eur J Immunol. 2021;46(4):509–515. doi: 10.5114/ceji.2021.111540
   PubMed Web of Science ®Google Scholar
• Cruz AR, Ramirez LG, Zuluaga AV, et al. Immune evasion and recognition of the syphilis spirochete in blood and skin of secondary syphilis patients: two immunologically distinct compartments. PLOS Negl Trop Dis. 2012;6(7):e1717. doi: 10.1371/journal.pntd.0001717
   PubMed Web of Science ®Google Scholar
• Zhuang YL, Zhu C-F, Zhang Y, et al. Association of KIR2DS4 and its variant KIR1D with syphilis in a Chinese han population. Int J Immunogenet. 2012;39(2):114–118. doi: 10.1111/j.1744-313X.2011.01063.x
   PubMed Web of Science ®Google Scholar
• Shimasaki N, Jain A, Campana D. NK cells for cancer immunotherapy. Nat Rev Drug Discov. 2020;19(3):200–218. doi: 10.1038/s41573-019-0052-1
   PubMed Web of Science ®Google Scholar
• Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells. Immunol Rev. 2006;214(1):130–142. doi: 10.1111/j.1600-065X.2006.00460.x
   PubMedGoogle Scholar
• Kim S, Sunwoo JB, Yang L, et al. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci USA. 2008;105(8):3053–3058. doi: 10.1073/pnas.0712229105
   PubMed Web of Science ®Google Scholar
• Moradi S, Stankovic S, O’Connor GM, et al. Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C. Nat Commun. 2021;12(1):2173. doi: 10.1038/s41467-021-22359-x
   PubMed Web of Science ®Google Scholar
• Fadda L, Borhis G, Ahmed P, et al. Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci USA. 2010;107(22):10160–10165. doi: 10.1073/pnas.0913745107
   PubMed Web of Science ®Google Scholar
• Palumbo JS, Talmage KE, Massari JV, et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood. 2005; 105(1):178–185. doi: 10.1182/blood-2004-06-2272
   PubMed Web of Science ®Google Scholar
• Palumbo JS, Barney KA, Blevins EA, et al. Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function. J Thromb Haemost. 2008;6(5):812–819. doi: 10.1111/j.1538-7836.2008.02938.x
   PubMed Web of Science ®Google Scholar
• Palumbo JS, Talmage KE, Massari JV, et al. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood, The J of the Am Soc of Hematol. 2007; 110(1):133–141. doi: 10.1182/blood-2007-01-065995
   Google Scholar
• Menter DG, Kopetz S, Hawk E, et al. Platelet “first responders” in wound response, cancer, and metastasis. Cancer Metastasis Rev. 2017;36(2):199–213. doi: 10.1007/s10555-017-9682-0
   PubMed Web of Science ®Google Scholar
• Church B, Wall E, Webb JR, et al. Interaction of Treponema pallidum, the syphilis spirochete, with human platelets. PLOS ONE. 2019;14(1):e0210902. doi: 10.1371/journal.pone.0210902
   PubMed Web of Science ®Google Scholar
• Binsker U, Palankar R, Wesche J, et al. Secreted immunomodulatory proteins of staphylococcus aureus activate platelets and induce platelet aggregation. Thromb Haemost. 2018;118(4):745–757. doi: 10.1055/s-0038-1637735
   Google Scholar
• McNicol A. Bacteria-induced intracellular signalling in platelets. Platelets. 2015;26(4):309–316. doi: 10.3109/09537104.2015.1014470
   PubMed Web of Science ®Google Scholar
• Coburn J, Leong JM, Erban JK. Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc Natl Acad Sci USA. 1993;90(15):7059–7063. doi: 10.1073/pnas.90.15.7059
   PubMed Web of Science ®Google Scholar
• Sanderson VP, Mainprize IL, Verzijlenberg L, et al. The platelet fraction is a novel reservoir to detect lyme Borrelia in blood. Biology. 2020;9(11). doi: 10.3390/biology9110366
   PubMedGoogle Scholar
• Xu QY, Wang Y-J, Lin L-R, et al. The outer membrane lipoprotein Tp0136 stimulates human platelet activation and aggregation through PAR1 to enhance G(q)/G(i) signaling. Front Immunol. 2022;13:818151. doi: 10.3389/fimmu.2022.818151
   PubMed Web of Science ®Google Scholar
• Tonn T, Becker S, Esser R, et al. Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92. J Hematother Stem Cell Res. 2001;10(4):535–544. doi: 10.1089/15258160152509145
   PubMedGoogle Scholar
• Arai S, Meagher R, Swearingen M, et al. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial. Cytotherapy. 2008;10(6):625–632. doi: 10.1080/14653240802301872
   PubMed Web of Science ®Google Scholar
• Becker PS, Suck G, Nowakowska P, et al. Selection and expansion of natural killer cells for NK cell-based immunotherapy. Cancer Immunol Immunother. 2016;65(4):477–484. doi: 10.1007/s00262-016-1792-y
   PubMed Web of Science ®Google Scholar
• Li QL, Xu Q-Y, Gao K, et al. Membrane location of cardiolipin antigen in Treponema pallidum: further study on the origin of nontreponemal antibodies. Future Microbiol. 2022;17(11):873–886. doi: 10.2217/fmb-2021-0245
   PubMed Web of Science ®Google Scholar
• Chen T, Wang K, Chi X, et al. Construction of a bacterial surface display system based on outer membrane protein F. Microb Cell Fact. 2019;18(1):70. doi: 10.1186/s12934-019-1120-2
   PubMedGoogle Scholar
• Borhis G, Ahmed PS, Mbiribindi B, et al. A peptide antagonist disrupts NK cell inhibitory synapse formation. J Immunol. 2013;190(6):2924–2930. doi: 10.4049/jimmunol.1201032
   PubMed Web of Science ®Google Scholar
• Wei ZH, Xie L, Wang Y-J, et al. Red blood cell lysis pretreatment can significantly improve the yield of Treponema pallidum DNA from blood. Microbiol Spectr. 2023;11(3):e0519822. doi: 10.1128/spectrum.05198-22
   PubMed Web of Science ®Google Scholar
• Marra CM, Tantalo LC, Sahi SK, et al. Reduced Treponema pallidum–specific opsonic antibody activity in HIV-Infected patients with syphilis. J Infect Dis. 2016;213(8):1348–1354. doi: 10.1093/infdis/jiv591
   PubMed Web of Science ®Google Scholar
• Li W, Li Q-L, Xu Q-Y, et al. Tp47 promoted the phagocytosis of HMC3 cells though autophagy induced by endoplamic reticlum stress. J Eur Acad Dermatol Venereol. 2022;36(11):2224–2234. doi: 10.1111/jdv.18295
   PubMed Web of Science ®Google Scholar
• Vijayan S, Sidiq T, Yousuf S, et al. Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance. Immunogenetics. 2019;71(3):273–282. doi: 10.1007/s00251-019-01106-z
   PubMed Web of Science ®Google Scholar
• Sivori S, Vacca P, Del Zotto G, et al. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications. Cell Mol Immunol. 2019;16(5):430–441. doi: 10.1038/s41423-019-0206-4
   PubMed Web of Science ®Google Scholar
• Lisovsky I, Kant S, Tremblay-McLean A, et al. Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC. J Leukocyte Biol. 2019;105(3):551–563. doi: 10.1002/JLB.4A0617-242RRR
   PubMed Web of Science ®Google Scholar
• Mujal AM, Delconte RB, Sun JC. Natural killer cells: from innate to adaptive features. Annu Rev Immunol. 2021;39(1):417–447. doi: 10.1146/annurev-immunol-101819-074948
   PubMedGoogle Scholar
• Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA. 1968;61(1):46–52. doi: 10.1073/pnas.61.1.46
   PubMed Web of Science ®Google Scholar
• Kao KJ. Selective elution of HLA antigens and β 2 -microglobulin from human platelets by chloroquine diphosphate. Transfusion. 1988;28(1):14–17. doi: 10.1046/j.1537-2995.1988.28188127942.x
   PubMed Web of Science ®Google Scholar
• Vivier E, Raulet DH, Moretta A, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331(6013):44–49. doi: 10.1126/science.1198687
   PubMed Web of Science ®Google Scholar
• Placke T, Örgel M, Schaller M, et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res. 2012;72(2):440–448. doi: 10.1158/0008-5472.CAN-11-1872
   PubMed Web of Science ®Google Scholar
• Dębska-Zielkowska J, Moszkowska G, Zieliński M, et al. KIR Receptors as key regulators of NK cells activity in health and disease. Cells. 2021;10(7):1777. doi: 10.3390/cells10071777
   PubMed Web of Science ®Google Scholar
• Deborska-Materkowska D, Perkowska-Ptasinska A, Sadowska-Jakubowicz A, et al. Killer immunoglobulin-like receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as genetic markers for stratifying the risk of cytomegalovirus infection in kidney transplant recipients. IJMS. 2019;20(3):20(3. doi: 10.3390/ijms20030546
   Google Scholar
• Sim MJ, Stowell J, Sergeant R, et al. KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells. Eur J Immunol. 2016;46(1):185–191. doi: 10.1002/eji.201545757
   PubMed Web of Science ®Google Scholar
• Long EO, Sik Kim H, Liu D, et al. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol. 2013;31(1):227–258. doi: 10.1146/annurev-immunol-020711-075005
   PubMedGoogle Scholar
• Kumar S. Natural killer cell cytotoxicity and its regulation by inhibitory receptors. Immunology. 2018;154(3):383–393. doi: 10.1111/imm.12921
   PubMed Web of Science ®Google Scholar
• Peterson ME and Long EO. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity. 2008;29(4):578–588. doi: 10.1016/j.immuni.2008.07.014
   PubMed Web of Science ®Google Scholar